Literature DB >> 2315288

Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer.

C Löser1, U R Fölsch, C Paprotny, W Creutzfeldt.   

Abstract

We investigated the total, free, and acetylated polyamine concentrations in pancreatic tissue, serum, and urine of 20 patients with pancreatic cancer, 30 healthy volunteers, and 40 patients with nonmalignant, gastrointestinal diseases by reversed-phase liquid chromatography. Tissue concentrations in carcinoma compared to histologically unaffected pancreas were significantly higher for putrescine, elevated for cadaverine, and nearly identical for spermidine and spermine, while N1-acetylspermidine was detectable in cancer tissue only. With the exception of free spermine in urine and total spermine in serum, all other polyamines were significantly elevated in the urine and serum of cancer patients compared to healthy controls. These data support the concept that polyamines play an important role in rapidly growing tissues. However, nonmalignant gastrointestinal diseases partly showed similar elevations. Because of this low specificity, polyamines are of little value only as diagnostic markers of pancreatic carcinoma. Since polyamine concentrations normalized in patients after curative operation while they were further elevated in patients with tumor relapse or metastases, polyamines might play a clinical role in predicting therapeutic success or indicating relapse of the tumor. A significant linear correlation of polyamine concentrations and the size of the tumor was found while a significant correlation to CEA, CA 19-9, and CA 125 or the presence of organ metastases did not exist.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315288     DOI: 10.1097/00006676-199003000-00001

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  17 in total

1.  activated polyamine catabolism in acute pancreatitis: alpha-methylated polyamine analogues prevent trypsinogen activation and pancreatitis-associated mortality.

Authors:  Mervi T Hyvönen; Karl-Heinz Herzig; Riitta Sinervirta; Elke Albrecht; Isto Nordback; Juhani Sand; Tuomo A Keinänen; Jouko Vepsäläinen; Nikolay Grigorenko; Alex R Khomutov; Burkhard Krüger; Juhani Jänne; Leena Alhonen
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

2.  Radiation metabolomics. 4. UPLC-ESI-QTOFMS-Based metabolomics for urinary biomarker discovery in gamma-irradiated rats.

Authors:  Caroline H Johnson; Andrew D Patterson; Kristopher W Krausz; Christian Lanz; Dong Wook Kang; Hans Luecke; Frank J Gonzalez; Jeffrey R Idle
Journal:  Radiat Res       Date:  2011-02-10       Impact factor: 2.841

Review 3.  A perspective of polyamine metabolism.

Authors:  Heather M Wallace; Alison V Fraser; Alun Hughes
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

4.  Genetic polymorphism in ornithine decarboxylase and risk of breast cancer.

Authors:  Iain Brown; Susan Halliday; Heather Greig; Steven D Heys; Heather M Wallace; Andrew C Schofield
Journal:  Fam Cancer       Date:  2009-02-19       Impact factor: 2.375

5.  Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.

Authors:  Altaf Mohammed; Naveena B Janakiram; Venkateshwar Madka; Rebekah L Ritchie; Misty Brewer; Laura Biddick; Jagan Mohan R Patlolla; Michael Sadeghi; Stan Lightfoot; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-23

Review 6.  The mechanisms by which polyamines accelerate tumor spread.

Authors:  Kuniyasu Soda
Journal:  J Exp Clin Cancer Res       Date:  2011-10-11

7.  Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-11-16       Impact factor: 3.876

8.  Elevated Polyamines in Saliva of Pancreatic Cancer.

Authors:  Yasutsugu Asai; Takao Itoi; Masahiro Sugimoto; Atsushi Sofuni; Takayoshi Tsuchiya; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Mitsuru Fujita; Kenjiro Yamamoto; Yukitoshi Matsunami; Takashi Kurosawa; Yuichi Nagakawa; Miku Kaneko; Sana Ota; Shigeyuki Kawachi; Motohide Shimazu; Tomoyoshi Soga; Masaru Tomita; Makoto Sunamura
Journal:  Cancers (Basel)       Date:  2018-02-05       Impact factor: 6.639

9.  Inhibition of Polyamine Biosynthesis Using Difluoromethylornithine Acts as a Potent Immune Modulator and Displays Therapeutic Synergy With PD-1-blockade.

Authors:  Parker Dryja; Carrie Fisher; Patrick M Woster; Eric Bartee
Journal:  J Immunother       Date:  2021-10-01       Impact factor: 4.912

10.  Investigation of Polyamine Metabolism and Homeostasis in Pancreatic Cancers.

Authors:  Chelsea Massaro; Jenna Thomas; Otto Phanstiel Iv
Journal:  Med Sci (Basel)       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.